Streetbeat News

Earnings

SLP

Simulations Plus (NASDAQ:SLP) reported Q2 2024 adjusted EPS of $0.20, surpassing the $0.19 estimate, with sales of $18.300M exceeding the $17.283M forecast. This represents a 16.19% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:09 pm

LEVI

Levi Strauss reported Q1 2024 adjusted EPS of $0.26, surpassing the $0.21 estimate, with sales of $1.558B also beating the $1.547B estimate. However, this represents a 7.76% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:08 pm

SPWH

Sportsman's Warehouse (SPWH) projects FY24 revenue to be between $1.15B-$1.23B, below the estimated $1.29B. The company aims for adjusted EBITDA of $45M-$65M and plans $20M-$25M in capital expenditures, mainly on technology for merchandising and store productivity. No new stores are expected to open. SPWH reduced its line of credit by $59.4M in Q4, focusing on inventory and cost management to lower bank borrowings and interest expenses.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:07 pm

SPWH

Sportsman's Warehouse (NASDAQ:SPWH) reported Q4 losses of $(0.20) per share, beating the $(0.30) estimate, but missed sales estimates with $370.39M against the expected $372.62M. This represents a significant decrease in earnings and a slight decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 8:06 pm

ORAAF

Aura Minerals (OTCQX:ORAAF) reported significant growth in its mineral reserves, with a notable stock performance increase of almost 16% over the last month. The company's exploration activities added 2.4 million ounces in measured and indicated reserves and 856,000 in proven and probable reserves. Key developments include increases in reserves at the Aranzazu mine in Mexico, Apoena mine in Honduras, and the Borborema project in Brazil. Aura Minerals also highlighted strong production results from the previous year and projected an increase in production for 2024, with net revenues surging by 164% since 2018.

Portfolio Pulse from Stjepan Kalinic

April 03, 2024 | 7:23 pm

M

Financial analysis reveals a bearish trend in options trading for Macy's (NYSE:M), with 88% of trades showing bearish tendencies. The analysis highlighted 9 unusual trades, with a significant portion being puts. The predicted price range for Macy's is between $15.0 to $22.0. Current trading volume and price indicate a neutral position, with an earnings announcement expected in 57 days. Analysts from JP Morgan and Telsey Advisory Group have set price targets at $25 and $21, respectively.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 7:16 pm

TEAM

Deep-pocketed investors have shown a bearish sentiment towards Atlassian (NASDAQ:TEAM), with unusual options activity detected. Benzinga's options scanner revealed 10 extraordinary activities, with 70% bearish and 30% bullish sentiment among these trades. The targeted price range for TEAM is between $180.0 and $240.0. The largest trades include both puts and calls, with a notable bearish sweep put at a strike price of $185.00 and a bullish call sweep at $200.00. Atlassian's current market standing shows a neutral RSI and a stable price of $196.02, with the next earnings report due in 22 days.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 7:01 pm

AVGO

Broadcom Inc. (NASDAQ:AVGO) has seen significant stock momentum, attributed to its focus on AI infrastructure, with a recent event highlighting its $10 billion AI chip sales forecast for the year. The stock surged 10% post-event and has shown a 113.47% increase over the past year. Analysts from Benchmark, JP Morgan, and Rosenblatt have set an average price target of $1640, indicating a 19.60% upside. Technical analysis supports a bullish outlook, with key levels to watch for further upside or potential pullback.

Portfolio Pulse from Surbhi Jain

April 03, 2024 | 6:48 pm

FGEN

FibroGen's shares dropped following the announcement of topline results from their Phase 1 study of FG-3246 in metastatic castration-resistant prostate cancer patients.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 6:43 pm

ABIO

AYI

CASA

KTRA

SINT

VIEW

VNDA

U.S. stocks traded higher with the NASDAQ gaining 75 points. Acuity Brands reported better-than-expected earnings, while Kintara Therapeutics and ARCA biopharma announced merger agreements. Vanda Pharmaceuticals received FDA approval for Fanapt. Casa Systems and View, Inc. filed for Chapter 11 bankruptcy, and Sintx Technologies announced a public offering.

Portfolio Pulse from Avi Kapoor

April 03, 2024 | 6:30 pm